64 related articles for article (PubMed ID: 23085261)
1. Cutl1: a potential target for cancer therapy.
Liu KC; Lin BS; Zhao M; Wang KY; Lan XP
Cell Signal; 2013 Jan; 25(1):349-54. PubMed ID: 23085261
[TBL] [Abstract][Full Text] [Related]
2. CUTL1: a key mediator of TGFbeta-induced tumor invasion.
Michl P; Downward J
Cell Cycle; 2006 Jan; 5(2):132-4. PubMed ID: 16357536
[TBL] [Abstract][Full Text] [Related]
3. CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation.
Aleksic T; Bechtel M; Krndija D; von Wichert G; Knobel B; Giehl K; Gress TM; Michl P
Oncogene; 2007 Aug; 26(40):5939-49. PubMed ID: 17369846
[TBL] [Abstract][Full Text] [Related]
4. CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.
Michl P; Ramjaun AR; Pardo OE; Warne PH; Wagner M; Poulsom R; D'Arrigo C; Ryder K; Menke A; Gress T; Downward J
Cancer Cell; 2005 Jun; 7(6):521-32. PubMed ID: 15950902
[TBL] [Abstract][Full Text] [Related]
5. CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
Wang J; Wang Y; Sun D; Ren F; Pang S; Xu S
Oncol Rep; 2017 May; 37(5):3068-3074. PubMed ID: 28405678
[TBL] [Abstract][Full Text] [Related]
6. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Liu ZM; Tseng JT; Hong DY; Huang HS
Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
8. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
Ripka S; König A; Buchholz M; Wagner M; Sipos B; Klöppel G; Downward J; Gress T; Michl P
Carcinogenesis; 2007 Jun; 28(6):1178-87. PubMed ID: 17227781
[TBL] [Abstract][Full Text] [Related]
9. Human cut-like repressor protein binds TGFbeta type II receptor gene promoter.
Jackson RJ; Antonia SJ; Wright KL; Moon NS; Nepveu A; Muñoz-Antonia T
Arch Biochem Biophys; 1999 Nov; 371(2):290-300. PubMed ID: 10545217
[TBL] [Abstract][Full Text] [Related]
10. TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration/invasion of urothelial carcinoma.
Huang HS; Liu ZM; Chen PC; Tseng HY; Yeh BW
Free Radic Biol Med; 2012 Aug; 53(4):769-78. PubMed ID: 22728270
[TBL] [Abstract][Full Text] [Related]
11. Differentiation-induced cleavage of Cutl1/CDP generates a novel dominant-negative isoform that regulates mammary gene expression.
Maitra U; Seo J; Lozano MM; Dudley JP
Mol Cell Biol; 2006 Oct; 26(20):7466-78. PubMed ID: 17015474
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
13. CUTL1 is phosphorylated by protein kinase A, modulating its effects on cell proliferation and motility.
Michl P; Knobel B; Downward J
J Biol Chem; 2006 Jun; 281(22):15138-44. PubMed ID: 16574653
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor CUTL1 is associated with proliferation and prognosis in malignant melanoma.
Fan X; Wang H; Zhou J; Wang S; Zhang X; Li T; Nie Y; Liu B
Melanoma Res; 2014 Jun; 24(3):198-206. PubMed ID: 24686420
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma.
Yeh BW; Wu WJ; Li WM; Li CC; Huang CN; Kang WY; Liu ZM; Huang HS
Am J Pathol; 2012 Sep; 181(3):1044-55. PubMed ID: 22771156
[TBL] [Abstract][Full Text] [Related]
16. The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions.
Luo L; Yang X; Takihara Y; Knoetgen H; Kessel M
Nature; 2004 Feb; 427(6976):749-53. PubMed ID: 14973489
[TBL] [Abstract][Full Text] [Related]
17. The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A.
van Gurp MF; Pratap J; Luong M; Javed A; Hoffmann H; Giordano A; Stein JL; Neufeld EJ; Lian JB; Stein GS; van Wijnen AJ
Cancer Res; 1999 Dec; 59(23):5980-8. PubMed ID: 10606245
[TBL] [Abstract][Full Text] [Related]
18. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
[TBL] [Abstract][Full Text] [Related]
19. Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt.
Essafi A; Gomes AR; Pomeranz KM; Zwolinska AK; Varshochi R; McGovern UB; Lam EW
Methods Mol Biol; 2009; 462():201-11. PubMed ID: 19160671
[TBL] [Abstract][Full Text] [Related]
20. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).
Hafsi S; Pezzino FM; Candido S; Ligresti G; Spandidos DA; Soua Z; McCubrey JA; Travali S; Libra M
Int J Oncol; 2012 Mar; 40(3):639-44. PubMed ID: 22200790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
